Alamar Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALMR Nasdaq 2836 alamarbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alamar Biosciences, Inc.

Does Alamar Biosciences (ALMR) Sit Above Fair Value After The Selloff? - Nov 5th, 2026 6:13 am
Alamar Biosciences to Participate in Upcoming Investor Conferences - Nov 4th, 2026 2:05 pm
Alamar Biosciences (ALMR) Q3 2026 Earnings Call Transcript - Nov 4th, 2026 9:32 am
Alamar Biosciences (ALMR) Could Be 15% Undervalued On Q3 Results And Guidance - Nov 4th, 2026 1:12 am
Alamar Biosciences Inc (ALMR) (Q3 2026) Earnings Call Highlights: Revenue Jumps 68% as Guidance ... - Nov 3rd, 2026 10:10 pm
Alamar Biosciences Q3 Earnings Call Highlights - Nov 3rd, 2026 5:14 pm
Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Nov 3rd, 2026 3:00 pm
Alamar: Q3 Earnings Snapshot - Nov 3rd, 2026 2:16 pm
Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue Guidance - Nov 3rd, 2026 2:05 pm
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine - Nov 3rd, 2026 2:03 pm
UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study - Nov 2nd, 2026 5:05 pm
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study - Nov 2nd, 2026 6:00 am
Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology - Oct 28th, 2026 2:05 pm
Kardigan And 2 Founder Run Stocks To Own - Oct 20th, 2026 9:15 am
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026 - Oct 8th, 2026 2:05 pm
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team - Oct 5th, 2026 2:05 pm
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment - Sep 24th, 2026 4:51 pm
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - Sep 1st, 2026 2:05 pm
Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript - Aug 17th, 2026 6:14 pm